Skip to content

Insider · CIK 0001674492

Timothy Warbington

ceopresidentofficerdirectorowner

Files at CELZ (CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.). First filing -, latest -.

In brief

Timothy Warbington files SEC Form 4 as CEO, president, director and 10% owner at CELZ (CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Timothy Warbington has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 24, 2026CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
AGrant or award
Common Stockindirect: By entity
+1,000,000--1,034,90418 d ago

Questions about Timothy Warbington

Answered from the filings on this page, as of the latest one.

Is Timothy Warbington buying or selling?

Timothy Warbington has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Timothy Warbington's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy Warbington has 0.

Where does Timothy Warbington file Form 4?

Timothy Warbington has filed Form 4 at CELZ (CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Timothy Warbington: insider trades and track record | InsiderTell